David A. Santos - 02 Feb 2024 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Signature
/s/ Raymond Furey (Attorney-in-Fact)
Issuer symbol
RIGL
Transactions as of
02 Feb 2024
Net transactions value
-$16,496
Form type
4
Filing time
06 Feb 2024, 20:18:59 UTC
Previous filing
25 Jan 2024
Next filing
01 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RIGL Common Stock Sale $6,329 -5,601 -1.5% $1.13 358,011 02 Feb 2024 Direct F1
transaction RIGL Common Stock Sale $10,167 -8,918 -2.5% $1.14 349,093 05 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.